Focused ultrasound could be a game-changer for urological conditions.

The technology has a significant track record in the treatment of prostate cancer, with more than 40,000 patients treated worldwide and 15 years of follow-up study data. To date, Europe and some regions of Asia have approved the use of focused ultrasound to treat prostate cancer and kidney cancer. In the US, two systems have been approved by the Food and Drug Administration (FDA) to treat abnormal prostate tissue, (including prostate cancer and benign prostate hypertrophy (BPH). Additional methods to treat the prostate, including MR-guidance and a trans-urethral approach, are being researched worldwide.

There is also clinical and preclinical research happening around the globe to assess the potential of the technology to treat kidney and bladder cancer, acute tubular necrosis, acute kidney injury, kidney stones and ureterocele.

Learn more about focused ultrasound for:

clinical stages key

Acute Kidney Injury Early Stage icon    
Acute Tubular Necrosis Early Stage icon    
Benign Prostatic Hyperplasia (BPH) FDA Approved icon Outside Approval icon Clinical Trials icon
Bladder Tumors Early Stage icon    
Chyluria Clinical Trials icon    
Kidney Tumors Outside Approval icon Clinical Trials icon  
Kidney Stones Clinical Trials icon    
Prostate Cancer FDA Approved icon Outside Approval icon Clinical Trials icon
Ureterocele Early Stage icon    
Urinary Tract Infection Early Stage icon    
Vasectomy Early Stage icon    

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Whitelist Instructions